Financhill
Back

Akebia Therapeutics Stock Predictions

Akebia Therapeutics Stock Forecast

  • Is Akebia Therapeutics Stock Undervalued?
    The current Akebia Therapeutics [AKBA] share price is $1.99. The Score for AKBA is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Akebia Therapeutics Stock Go Up Next Year?

Data Unavailable

Akebia Therapeutics Stock Rating

Data Unavailable

Akebia Therapeutics Stock Price History

Is AKBA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akebia.com

52-Week Data

52-Week High:
2.48
52-Week Low:
0.80

Prediction Charts

Market Cap:
418.47M
Price in USD:
1.99
Volume:
2.89M
Beta:
0.99

Technical Analysis

SMA50:
1.48
SMA100:
1.37
SMA200:
1.40
52-Wk Change:
122.84%

Stock Predictions

  • Is Akebia Therapeutics stock public?
    Yes, Akebia Therapeutics is a publicly traded company.
  • What is the Akebia Therapeutics stock quote today?
    The Akebia Therapeutics stock price is 1.99 USD today.
  • How to buy Akebia Therapeutics stock online?
    You can buy Akebia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 1.69 1.59 1.69 1.54
Oct-24 1.60 1.58 1.69 1.56
Oct-25 1.57 1.59 1.63 1.57
Oct-28 1.59 1.63 1.66 1.59
Oct-29 1.62 1.71 1.72 1.61
Oct-30 1.70 1.70 1.74 1.63
Oct-31 1.70 1.66 1.72 1.66
Nov-1 1.70 1.69 1.75 1.68
Nov-4 1.72 1.85 1.85 1.70
Nov-5 1.85 1.86 1.86 1.78
Nov-6 1.85 2.00 2.01 1.85
Nov-7 1.74 1.87 1.91 1.67
Nov-8 1.84 1.94 1.95 1.79
Nov-11 1.92 1.99 2.02 1.90

Akebia Therapeutics Earnings

Data Unavailable

Akebia Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.